Earnings Call: CorMedix Inc. Reports Q3 Financials, Driven by DefenCath Growth
Daily NewsRecently, at a financial results conference call, CorMedix Inc. (NYSE American: CRMD) reported significant progress in the third quarter of 2024. Net revenue reac...
Read More